Baillie Gifford & Co
MYOK

Baillie Gifford & Co’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Baillie Gifford & Co’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,993
Closed -$2.86M – 437
2020
Q3 		$2.86M Buy
+20,993
New +$2.23M ﹤0.01% 225

Baillie Gifford & Co's MYOK Position: Q4 2020 in Review

Baillie Gifford & Co sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 20,993 shares — an estimated $2.86M sold.

Baillie Gifford & Co first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $2.86M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Baillie Gifford & Co reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Baillie Gifford & Co sold 20,993 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.86M.
  • Baillie Gifford & Co first reported a position in MyoKardia, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Baillie Gifford & Co's MyoKardia, Inc. Common Stock position peaked at $2.86M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Baillie Gifford & Co's 13F filing for Q4 2020, filed 10 Feb 2021.